These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 28780934)

  • 1. SOX4: Joining the Master Regulators of Epithelial-to-Mesenchymal Transition?
    Lourenço AR; Coffer PJ
    Trends Cancer; 2017 Aug; 3(8):571-582. PubMed ID: 28780934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SOX4 induces epithelial-mesenchymal transition and contributes to breast cancer progression.
    Zhang J; Liang Q; Lei Y; Yao M; Li L; Gao X; Feng J; Zhang Y; Gao H; Liu DX; Lu J; Huang B
    Cancer Res; 2012 Sep; 72(17):4597-608. PubMed ID: 22787120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SOX4: Epigenetic regulation and role in tumorigenesis.
    Hanieh H; Ahmed EA; Vishnubalaji R; Alajez NM
    Semin Cancer Biol; 2020 Dec; 67(Pt 1):91-104. PubMed ID: 31271889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of SOX4 promotes cell migration and invasion of renal cell carcinoma by inducing epithelial-mesenchymal transition.
    Ruan H; Yang H; Wei H; Xiao W; Lou N; Qiu B; Xu G; Song Z; Xiao H; Liu L; Zhou Y; Hu W; Chen K; Chen X; Zhang X
    Int J Oncol; 2017 Jul; 51(1):336-346. PubMed ID: 28534986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-200c: a versatile watchdog in cancer progression, EMT, and drug resistance.
    Mutlu M; Raza U; Saatci Ö; Eyüpoğlu E; Yurdusev E; Şahin Ö
    J Mol Med (Berl); 2016 Jun; 94(6):629-44. PubMed ID: 27094812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SOX4 induces tumor invasion by targeting EMT-related pathway in prostate cancer.
    Liu Y; Zeng S; Jiang X; Lai D; Su Z
    Tumour Biol; 2017 May; 39(5):1010428317694539. PubMed ID: 28466783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metformin inhibits epithelial-mesenchymal transition in prostate cancer cells: involvement of the tumor suppressor miR30a and its target gene SOX4.
    Zhang J; Shen C; Wang L; Ma Q; Xia P; Qi M; Yang M; Han B
    Biochem Biophys Res Commun; 2014 Sep; 452(3):746-52. PubMed ID: 25201727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SRY-related high-mobility-group box 4: Crucial regulators of the EMT in cancer.
    Wu X; Xin Z; Zou Z; Lu C; Yu Z; Feng S; Pan P; Hao G; Dong Y; Yang Y
    Semin Cancer Biol; 2020 Dec; 67(Pt 1):114-121. PubMed ID: 31199986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alternative splicing modulates cancer aggressiveness: role in EMT/metastasis and chemoresistance.
    Roy Burman D; Das S; Das C; Bhattacharya R
    Mol Biol Rep; 2021 Jan; 48(1):897-914. PubMed ID: 33400075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sox4 is a master regulator of epithelial-mesenchymal transition by controlling Ezh2 expression and epigenetic reprogramming.
    Tiwari N; Tiwari VK; Waldmeier L; Balwierz PJ; Arnold P; Pachkov M; Meyer-Schaller N; Schübeler D; van Nimwegen E; Christofori G
    Cancer Cell; 2013 Jun; 23(6):768-83. PubMed ID: 23764001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiR-363-3p inhibits the epithelial-to-mesenchymal transition and suppresses metastasis in colorectal cancer by targeting Sox4.
    Hu F; Min J; Cao X; Liu L; Ge Z; Hu J; Li X
    Biochem Biophys Res Commun; 2016 May; 474(1):35-42. PubMed ID: 27084453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A TGF-β-MTA1-SOX4-EZH2 signaling axis drives epithelial-mesenchymal transition in tumor metastasis.
    Li L; Liu J; Xue H; Li C; Liu Q; Zhou Y; Wang T; Wang H; Qian H; Wen T
    Oncogene; 2020 Mar; 39(10):2125-2139. PubMed ID: 31811272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emerging Mechanisms by which EMT Programs Control Stemness.
    Wilson MM; Weinberg RA; Lees JA; Guen VJ
    Trends Cancer; 2020 Sep; 6(9):775-780. PubMed ID: 32312682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ETS1 promoted cell growth, metastasis and epithelial-mesenchymal transition process in melanoma by regulating miR-16-mediated SOX4 expression.
    Yang LX; Guo HB; Liu SY; Feng HP; Shi J
    Melanoma Res; 2021 Aug; 31(4):298-308. PubMed ID: 34039939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of SRY-related HMG box transcription factor 4 (SOX4) in tumorigenesis and metastasis: friend or foe?
    Vervoort SJ; van Boxtel R; Coffer PJ
    Oncogene; 2013 Jul; 32(29):3397-409. PubMed ID: 23246969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of miR-204 enables oral squamous cell carcinomas to promote cancer stemness, EMT traits, and lymph node metastasis.
    Yu CC; Chen PN; Peng CY; Yu CH; Chou MY
    Oncotarget; 2016 Apr; 7(15):20180-92. PubMed ID: 26933999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A crucial epithelial to mesenchymal transition regulator, Sox4/Ezh2 axis is closely related to the clinical outcome in pancreatic cancer patients.
    Hasegawa S; Nagano H; Konno M; Eguchi H; Tomokuni A; Tomimaru Y; Asaoka T; Wada H; Hama N; Kawamoto K; Marubashi S; Nishida N; Koseki J; Mori M; Doki Y; Ishii H
    Int J Oncol; 2016 Jan; 48(1):145-52. PubMed ID: 26648239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sox4, EMT programs, and the metastatic progression of breast cancers: mastering the masters of EMT.
    Parvani JG; Schiemann WP
    Breast Cancer Res; 2013; 15(4):R72. PubMed ID: 23981787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Telomerase reverse transcriptase promotes epithelial-mesenchymal transition and stem cell-like traits in cancer cells.
    Liu Z; Li Q; Li K; Chen L; Li W; Hou M; Liu T; Yang J; Lindvall C; Björkholm M; Jia J; Xu D
    Oncogene; 2013 Sep; 32(36):4203-13. PubMed ID: 23045275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multilayer control of the EMT master regulators.
    Zheng H; Kang Y
    Oncogene; 2014 Apr; 33(14):1755-63. PubMed ID: 23604123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.